Lukas Angleitner-Boubenizek

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

Chee Khoon Lee, R. J. Simes, Chris Brown et al. · British Journal of Cancer · 2011 · 38 citations · Full text

Medicine, Biostatistics, Oncology +16

Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum–taxane therapy: A phase II Austrian AGO study

Edgar Petru, Lukas Angleitner-Boubenizek, Alexander Reinthaller et al. · Gynecologic Oncology · 2006 · 30 citations

Medicine, Oncology, Pharmacology +17

Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study

Jalid Sehouli, Alexander Reinthaller, Christian Marth et al. · British Journal of Cancer · 2014 · 16 citations · Full text

Medicine, Oncology, Surgery +17

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)

Birgit Volgger, Gudrun Windbichler, Alain G. Zeimet et al. · Annals of Oncology · 2016 · 11 citations

Medicine, Gynecology, Oncology +9